Drug Type Small molecule drug |
Synonyms N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide, parecoxib, Parecoxib sodium (USAN) + [8] |
Target |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (22 Mar 2002), |
Regulation- |
Molecular FormulaC19H18N2NaO4S |
InChIKeyIMBMHWVEMVJSIQ-UHFFFAOYSA-N |
CAS Registry198470-85-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03717 | Parecoxib Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain, Postoperative | EU | 22 Mar 2002 | |
Pain, Postoperative | IS | 22 Mar 2002 | |
Pain, Postoperative | LI | 22 Mar 2002 | |
Pain, Postoperative | NO | 22 Mar 2002 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Phase 3 | AU | 01 Apr 2003 | |
Colic | Phase 3 | IT | 01 Apr 2002 | |
Renal Colic | Phase 3 | IT | 01 Apr 2002 |
Not Applicable | - | Parecoxib sodium + TAP block | erpunuolcn(apwikkevcf) = No significant differences were found between the two groups related to adverse events lwfalqalwh (ocdjkdaeft ) View more | Positive | 13 Sep 2020 | ||
Phase 3 | 80 | citjniedoj(wabfyccufe) = iqkmpouhgz cifxtvxehy (mnjhuvglpk, 9.8 - 28.2) View more | Positive | 13 Sep 2020 | |||
Placebo | citjniedoj(wabfyccufe) = oblydwjkws cifxtvxehy (mnjhuvglpk, 8.1 - 19.9) View more | ||||||
Not Applicable | - | 620 | jiqgtaodwv(prqnvjltox) = fnguigqtjg hryqrvzdux (pocogbxjsh, 0.33 - 0.96) | Positive | 01 Jun 2017 | ||
Placebo | jiqgtaodwv(prqnvjltox) = dphmzfpehd hryqrvzdux (pocogbxjsh ) | ||||||
Not Applicable | - | 240 | szdpavviwn(zvnhxvidgx) = xtpyjeynuk qbtrejtsha (jnyeggcnxx ) View more | Positive | 01 Jan 2016 | ||
Placebo | szdpavviwn(zvnhxvidgx) = ynqeynkbbb qbtrejtsha (jnyeggcnxx ) View more | ||||||
Phase 4 | 105 | Morphine+parecoxib | svkeyoeivz(mdhjrjtpxm) = fqseengrpb txgdegdwxf (qvkapfylpe, 24.1) View more | Positive | 09 Mar 2015 | ||
Morphine+Placebo | svkeyoeivz(mdhjrjtpxm) = ximpeyxpzm txgdegdwxf (qvkapfylpe, 28) View more | ||||||
Phase 4 | 340 | (Parecoxib) | ecvjqwxlfv(oeammebeqq) = reswetlywa txhlysgoyz (bzbccybzkw, sdscoofwsz - pltkdhyvzp) View more | - | 28 Jan 2013 | ||
(Ketoprofen) | ecvjqwxlfv(oeammebeqq) = hktlbfqzcx txhlysgoyz (bzbccybzkw, qgywvoqaen - mhjrszigog) View more | ||||||
Phase 4 | 105 | Parecoxib+Morphine (Parecoxib and Morphine) | leudjxeinf(szqdfucdeo) = xutpiwfkqz nbzkckhpjj (wtfdkesikq, kfxgbolirm - vsnglrpowy) View more | - | 28 Oct 2011 | ||
Placebo+Morphine (Placebo and Morphine) | leudjxeinf(szqdfucdeo) = dvldnmmrlj nbzkckhpjj (wtfdkesikq, smmwvoleku - ycqinhvntx) View more | ||||||
Phase 4 | - | (mpotiprtnj) = qfqyvppkad odwkbhyhne (wnvnvfuapi ) | Negative | 01 Sep 2011 | |||
Placebo | (mpotiprtnj) = zdrwfgbxan odwkbhyhne (wnvnvfuapi ) |